{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T18:31:45Z","timestamp":1768415505095,"version":"3.49.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T00:00:00Z","timestamp":1563321600000},"content-version":"vor","delay-in-days":197,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Surgery Case Reports"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/j.ijscr.2019.07.014","type":"journal-article","created":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T20:01:52Z","timestamp":1563566512000},"page":"107-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Massively distended, necrotic and hemorrhagic gallbladder in a long-term octreotide-treated patient with added everolimus"],"prefix":"10.1097","volume":"61","author":[{"given":"Eric","family":"Bergeron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bensoussan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"5","key":"10.1016\/j.ijscr.2019.07.014_bib0005","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.dld.2018.09.013","article-title":"Biliary stone disease in patients receiving somatostatin analogs for neuroendocrine neoplasms. A retrospective observational study","volume":"51","author":"Brighi","year":"2019","journal-title":"Dig Liver Dis"},{"issue":"3","key":"10.1016\/j.ijscr.2019.07.014_bib0010","doi-asserted-by":"crossref","DOI":"10.1002\/hep.1840210309","article-title":"The natural history of gallstones: the GREPCO experience","volume":"21","author":"Attili","year":"1995","journal-title":"Hepatology."},{"issue":"6","key":"10.1016\/j.ijscr.2019.07.014_bib0015","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.bpg.2006.05.004","article-title":"Gallstone disease: epidemiology of gallbladder stone disease","volume":"20","author":"Shaffer","year":"2006","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"7614","key":"10.1016\/j.ijscr.2019.07.014_bib0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/bmj.39267.452257.AD","article-title":"Gallstones","volume":"335","author":"Sanders","year":"2007","journal-title":"BMJ."},{"issue":"1","key":"10.1016\/j.ijscr.2019.07.014_bib0025","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jhep.2016.03.005","article-title":"EASL clinical practice guidelines on the prevention, diagnosis and treatment of gallstones","volume":"65","author":"European Association for the Study of the Liver (EASL)","year":"2016","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.ijscr.2019.07.014_bib0030","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s00268-010-0428-1","article-title":"Prophylactic cholecystectomy in midgut carcinoid patients","volume":"34","author":"Norl\u00e9n","year":"2010","journal-title":"World J. Surg."},{"issue":"8","key":"10.1016\/j.ijscr.2019.07.014_bib0035","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/BF03346419","article-title":"Somatostatin analogs and gallstones: a retrospective survey on a large series of acromegalic patients","volume":"31","author":"Attanasio","year":"2008","journal-title":"J. Endocrinol. Invest."},{"issue":"3","key":"10.1016\/j.ijscr.2019.07.014_bib0040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2265.1994.tb03938.x","article-title":"Cholelithiasis and acromegaly: therapeutic strategies","volume":"409","author":"Montini","year":"1994","journal-title":"Clin. Endocrinol. (Oxf) (Oxf)"},{"issue":"4","key":"10.1016\/j.ijscr.2019.07.014_bib0045","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<830::AID-CNCR20>3.0.CO;2-#","article-title":"Incidence and morbidity of cholelithiasis in patients receiving chronic octreotide for metastatic carcinoid and malignant islet cell tumors","volume":"79","author":"Trendle","year":"1997","journal-title":"Cancer."},{"issue":"8","key":"10.1016\/j.ijscr.2019.07.014_bib0050","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1517\/14740338.2015.1059817","article-title":"Adverse events associated with somatostatin analogs in acromegaly","volume":"14","author":"Grasso","year":"2015","journal-title":"Expert Opin. Drug Saf."},{"issue":"1","key":"10.1016\/j.ijscr.2019.07.014_bib0055","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1245\/s10434-013-3300-3","article-title":"Review of the impact of antineoplastic therapies on the risk for cholelithiasis and acute cholecystitis","volume":"21","author":"Jayakrishnan","year":"2014","journal-title":"Ann. Surg. Oncol."},{"issue":"60","key":"10.1016\/j.ijscr.2019.07.014_bib0060","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijsu.2018.10.028","article-title":"The SCARE 2018 Statement: Updating Consensus Surgical CAse REport (SCARE) Guidelines","author":"Agha","year":"2018","journal-title":"International Journal of Surgery"},{"key":"10.1016\/j.ijscr.2019.07.014_bib0065","series-title":"Sleiseger and Fordtran\u2019s Gastrointestinal and Liver Disease","first-page":"519","article-title":"Neuroendocrine tumors: somatostatinoma","author":"Jensen","year":"2016"},{"key":"10.1016\/j.ijscr.2019.07.014_bib0070","series-title":"Endotext","article-title":"Somatostatinoma","author":"Vinik","year":"2017"},{"issue":"28","key":"10.1016\/j.ijscr.2019.07.014_bib0075","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","article-title":"Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID study Group","volume":"27","author":"Rinke","year":"2009","journal-title":"J Clin Oncol."},{"issue":"3","key":"10.1016\/j.ijscr.2019.07.014_bib0080","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1316158","article-title":"Lanreotide in metastatic enteropancreatic neuroendocrine tumors","volume":"371","author":"Caplin","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ijscr.2019.07.014_bib0085","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/1078155210363317","article-title":"Acute cholecystis in a patient with metastatic renal cell carcinoma treated with everolimus","volume":"17","author":"Cetin","year":"2011","journal-title":"J Oncol Pharm Pract."},{"key":"10.1016\/j.ijscr.2019.07.014_bib0090","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.2147\/TCRM.S144975","article-title":"Immunosuppressants and new onset gallstone disease in patients having undergone renal transplantation","volume":"13","author":"Liu","year":"2017","journal-title":"Ther. Clin. Risk Manag."}],"container-title":["International Journal of Surgery Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261219303967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261219303967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T10:41:03Z","timestamp":1768387263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210261219303967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":18,"alternative-id":["S2210261219303967"],"URL":"https:\/\/doi.org\/10.1016\/j.ijscr.2019.07.014","relation":{},"ISSN":["2210-2612"],"issn-type":[{"value":"2210-2612","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Massively distended, necrotic and hemorrhagic gallbladder in a long-term octreotide-treated patient with added everolimus","name":"articletitle","label":"Article Title"},{"value":"International Journal of Surgery Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijscr.2019.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.","name":"copyright","label":"Copyright"}]}}